Revise Measuring non-adherence for Cambridge 9990 (3.2.2)

Measuring patient adherence to medical advice is crucial for both clinical practice and research, yet it presents a significant challenge. Effective measurement allows clinicians to understand why a treatment might be failing and helps researchers to accurately assess the efficacy of new interventions. However, there is no single 'gold standard' method for measuring adherence. Each available technique, from asking the patient directly to analysing their blood, comes with a unique set of strengths and limitations. Broadly, these methods can be categorised as either subjective (relying on patient reports) or objective (relying on physical evidence). The choice of method often involves a trade-off between accuracy, cost, practicality, and the specific information required.

Self-report measures involve asking patients about their adherence behaviour through interviews, diaries, or standardised questionnaires like the Medication Adherence Report Scale (MARS). This is the most common method used in clinical practice because it is inexpensive, easy to administer, and non-invasive. A key strength is its ability to provide qualitative data, helping practitioners understand the reasons and beliefs behind non-adherence. However, its primary weakness is its reliance on patient honesty and memory. The data is susceptible to both social desirability bias, where patients overstate adherence to please their doctor, and recall bias, where they simply forget instances of non-adherence. Consequently, self-report measures consistently overestimate adherence levels compared to objective methods.

Pill counting is a simple, quantitative, and objective method of estimating adherence. At a follow-up appointment, the clinician counts the number of pills remaining in the medication bottle and subtracts this from the number that should have been taken during that period. While more objective than self-report, this method has a critical flaw: it does not confirm ingestion. It only measures the removal of medication from the container. A patient wishing to appear adherent can easily discard the pills without taking them, a practice known as 'pill dumping'. Therefore, while pill counts can provide evidence of non-adherence if many pills remain, a seemingly 'correct' count is not definitive proof of adherence.

Biochemical tests are widely regarded as the most objective method for confirming adherence, as they provide direct physical evidence of ingestion. This involves analysing a patient's bodily fluids, such as blood or urine, to detect the presence of the drug or its metabolites. While highly accurate in confirming recent use, this method has significant practical disadvantages. The tests are invasive, expensive, and require specialised laboratory facilities, making them unsuitable for routine clinical monitoring. Furthermore, most drugs have a short half-life, meaning the test can only confirm adherence within a narrow time window (e.g., the last 24-48 hours). This can lead to the phenomenon of 'white-coat adherence', where a patient takes their medication just before an appointment to pass the test.